Clinical Trials Browser

Unknown × INDUSTRY × ascrinvacumab × Clear all

NCT05178043 2024-02-22

GT90001 Plus Nivolumab in Patients With Advanced Hepatocellular Carcinoma

Phase 2 Unknown

Gastrointestinal

Carcinoma, Hepatocellular